Serum or cerebrospinal fluid levels of glyceraldehyde-derived advanced glycation end products (AGEs) may be a promising biomarker for early detection of Alzheimer’s disease

✍ Scribed by S. Yamagishi; K. Nakamura; H. Inoue; S. Kikuchi; M. Takeuchi

• Book ID: 116742563
• Publisher: Elsevier Science
• Year: 2005
• Tongue: English
• Weight: 74 KB
• Volume: 64
• Category: Article
• ISSN: 0306-9877
• DOI: 10.1016/j.mehy.2005.01.016